CLINICAL OUTCOMES OF CHILDREN WITH CYSTIC FIBROSIS TREATED WITH INTRAVENOUS TOBRAMYCIN BASED ON A PHARMACOKINETIC ASSESMENT

被引：0
|
作者：
Abrahamsen, K. [1 ,2 ]
Nielsen, K. G. [3 ]
Petersen, K. L. [4 ]
Milla, C. E. [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Pediat, Ctr Excellence Pulm Biol, Palo Alto, CA 94304 USA
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Rigshosp, Dept Pediat & Adolescent Med, DK-2100 Copenhagen, Denmark
[4] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
222
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [21] Population Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis
    Praet, Antonin
    Bourguignon, Laurent
    Vetele, Florence
    Breant, Valentine
    Genestet, Charlotte
    Dumitrescu, Oana
    Doleans-Jordheim, Anne
    Reix, Philippe
    Goutelle, Sylvain
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [22] ANALYSIS OF PHARMACOKINETIC MONITORING OF TOBRAMYCIN FOR ADULT HOME INFUSION PATIENTS WITH CYSTIC FIBROSIS
    Burchill, A.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 343 - 343
  • [23] Evaluation of Target Attainment for Tobramycin in Children and Adults with Cystic Fibrosis
    Struiken, Sheseira T. L.
    Lobee, Danique
    van Tuinen, Eline L.
    Touw, Daniel J.
    van der Vaart, Hester
    Bourgonje, Arno R.
    Rottier, Bart L.
    Koppelman, Gerard H.
    Mian, Paola
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [24] Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis
    Clavel, Aurelie
    Boulamery, Audrey
    Bosdure, Emmanuelle
    Luc, Caroline
    Lanteaume, Andre
    Gorincour, Guillaume
    Stremler-Lebel, Nathalie
    Sarles, Jacques
    Andrieu, Veronique
    Dubus, Jean-Christophe
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (02) : 137 - 143
  • [25] Do children with cystic fibrosis receiving outreach care have poorer clinical outcomes than those treated at a specialist cystic fibrosis centre?
    Weber, Heinrich C.
    Robinson, Philip F.
    Saxby, Nicole
    Beggs, Sean A.
    Els, Ingrid
    Ehrlich, Rodney I.
    AUSTRALIAN JOURNAL OF RURAL HEALTH, 2017, 25 (01) : 34 - 41
  • [26] Social Determinants of Health and Clinical Outcomes in Children With Cystic Fibrosis
    De laosa, M.
    Ayub, J.
    Bilinski, S.
    Fultz, M.
    Pettit, R.
    Chmiel, J. F.
    Sanders, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [27] Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
    Sawicki, Gregory S.
    Signorovitch, James E.
    Zhang, Jie
    Latremouille-Viau, Dominick
    von Wartburg, Markus
    Wu, Eric Q.
    Shi, Lizheng
    PEDIATRIC PULMONOLOGY, 2012, 47 (01) : 44 - 52
  • [28] A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
    Hodson, ME
    Gallagher, CG
    Govan, JRW
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) : 658 - 664
  • [29] Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis
    Adams, JP
    Conway, SP
    Wilson, C
    RESPIRATORY MEDICINE, 1998, 92 (03) : 602 - 604
  • [30] Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis
    Downes, Kevin J.
    Dong, Min
    Fukuda, Tsuyoshi
    Clancy, John P.
    Haffner, Christopher
    Bennett, Michael R.
    Vinks, Alexander A.
    Goldstein, Stuart L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 254 - 260
12345